In this prospective cohort of patients with acute myocardial infarction (AMI), plasma progranulin levels increased acutely ...

Valuably, the NUDGE-FLU results point to “what message will resonate with an unsure, high-risk group with a history of ...

CHICAGO, IL—Spironolactone given to patients who have undergone PCI following an acute myocardial infarction has no impact on ...

Over 2 decades ago, the aldosterone antagonist eplerenone proved beneficial after MI complicated by left ventricular ...

According to a new study, the risk of heart failure and cardiovascular death also occurs in people who try to compensate by ...

For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...

The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...

Delaying noncardiac surgeries for three to six months following a heart attack appears safer for those who undergo r ...

The study suggests non-fermented milk may raise ischemic heart disease risk in women, urging a closer look at dairy ...

Mean achieved blood pressure in the two groups was 120.6 mm Hg in the intensive-treatment group and 132.1 mm Hg in the ...

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

WASHINGTON — Colchicine does not protect against major cardiovascular adverse events after an acute myocardial infarction, according to a multinational placebo-controlled trial of more than 7000 ...